Potbelly Corporation Reports Strong Results for Fourth Fiscal Quarter and Full Year 2023
Fourth quarter same-store sales growth of 6.3% and AWS of $24,960, with traffic growth as a major driver 202 new […]
RadNet Announces Proposed $200 Million Underwritten Public Offering of Common Stock
LOS ANGELES, March 07, 2024 (GLOBE NEWSWIRE) — RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site […]
Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024
CARLSBAD, Calif., March 07, 2024 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, will release […]
Noodles & Company Announces Appointment of Drew Madsen as CEO
BROOMFIELD, Colo., March 07, 2024 (GLOBE NEWSWIRE) — Noodles & Company (Nasdaq: NDLS) today announced that the Board has appointed […]
HF Foods to Report Fourth Quarter and Full Year 2023 Results on March 14, 2024
LAS VEGAS, March 07, 2024 (GLOBE NEWSWIRE) — HF Foods Group Inc. (NASDAQ: HFFG) (“HF Foods”, or the “Company”), a […]
Concrete Pumping Holdings Reports First Quarter Fiscal Year 2024 Results
DENVER, March 07, 2024 (GLOBE NEWSWIRE) — Concrete Pumping Holdings, Inc. (Nasdaq: BBCP) (the “Company” or “CPH”), a leading provider […]
El Pollo Loco Holdings, Inc. Announces Fourth Quarter 2023 Financial Results
COSTA MESA, Calif., March 07, 2024 (GLOBE NEWSWIRE) — El Pollo Loco Holdings, Inc. (Nasdaq: LOCO) today announced financial results for […]
Oxbridge Re Announces 2023 Fourth Quarter Results on March 26, 2024
GRAND CAYMAN, Cayman Islands, March 07, 2024 (GLOBE NEWSWIRE) — Oxbridge Re (NASDAQ: OXBR) announced that it plans to hold […]
red violet Announces Fourth Quarter and Full Year 2023 Financial Results
Fourth Quarter Revenue Increased 15% to $15.1 Million Producing $4.2 Million of Cash Flow from Operations Full Year 2023 Revenue […]
TSX News -
Profound Medical Announces Fourth Quarter and Full Year 2023 Financial Results
TORONTO, March 07, 2024 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device […]
